M&A Deal Summary

Crown Laboratories Acquires Crown Aesthetics

On September 27, 2018, Crown Laboratories acquired medical products company Crown Aesthetics

Acquisition Highlights
  • This is Crown Laboratories’ 1st transaction in the Medical Products sector.
  • This is Crown Laboratories’ 1st transaction in the United States.
  • This is Crown Laboratories’ 1st transaction in Texas.

M&A Deal Summary

Date 2018-09-27
Target Crown Aesthetics
Sector Medical Products
Buyer(s) Crown Laboratories
Deal Type Add-on Acquisition

Target

Crown Aesthetics

Dallas, Texas, United States
Crown Aesthetics is a medical aesthetics treatments company dedicated to delivering innovative repair and restoration products to aesthetic practices around the world. Bellus’s non-invasive products give it a unique position in aesthetics, providing a range of products that draw first-time consumers to leading physician-directed practices globally. Most notable among its products is the SkinPen – a medical-grade micro-needling device used exclusively by healthcare professionals to improve the appearance of facial acne scars – the first micro-needling device in the industry to be granted clearance and marketing authorization by the U.S. Food and Drug Administration (FDA) for this indication. Crown Aesthetics was founded in 2012 and is based in Dallas, Texas.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Crown Laboratories

Johnson City, Tennessee, United States

Category Company
Founded 2000
Sector Life Science
DESCRIPTION

Crown Laboratories is a specialty pharmaceutical company that produces medical products such as Blue Lizard Australian Sunscreen and medical products AlaQuin, AlaScalp, and Daxbia. Crown Laboratories currently operates three distinct areas of focus related to skincare and treating skin-related conditions: Consumer Healthcare Products, Prescription Products, and Contract Development and Manufacturing Services. Crown Laboratories was founded in 2000 and is based in Johnson City, Tennessee.


DEAL STATS #
Overall 2 of 7
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 2 of 4
State (Texas) 1 of 2
Country (United States) 1 of 4
Year (2018) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-05 Vita Liberata

Johnson City, Tennessee, Ireland

Vita Liberata is an Ireland-based company with advanced organic formulations, specializing in sunless tanning and skincare products. Vita Liberata was the first completely non-toxic tanning brand, with a collection of odorless products free from parabens, perfume, and alcohol. Vita Liberata products employ the company’s proprietary Advoganic™ Technology, which combines cutting edge skin chemistry with highly potent organic botanicals. Vita Liberata was founded in 2003 and is based in Johnson City, Tennessee.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-30 GlaxoSmithKline - Consumer Healthcare Portfolio

Brentford, United Kingdom

GlaxoSmithKline plc - Consumer Healthcare Portfolio has long been regarded as high quality, safe and effective, maintaining a quality image and loyal base of consumers. OTC medications allow practitioners and their patients the ability to access therapeutic products while reducing the burden of prescription drug costs on the healthcare system. The products expand Crown Laboratories’ consumer portfolio by adding #1 in category brands that treat multiple conditions. The acquired portfolio includes PanOxyl®: #1 Dermatologist recommended daily acne wash Sarna®: #1 Dermatology recommended anti-itch lotion Zeasorb®: #1 Dermatologist recommended anti-fungal and prevention product Desenex®: Anti-fungal powder for athlete’s foot Mineral Ice®: Leading pain-relieving gel.

Buy -